Morin Prevents Non-Alcoholic Hepatic Steatosis in Obese Rats by Targeting the Peroxisome Proliferator-Activated Receptor Alpha (PPARα).

Published in: Life (Basel, Switzerland) (2024)

These findings suggest the potential use of morin to enhance fatty acid oxidation in white adipose tissue and mitigate obesity, warranting further clinical investigation into its therapeutic applications.

Keyphrases

adipose tissue
insulin resistance
fatty acid
metabolic syndrome
weight loss
high fat diet
high fat diet induced
type diabetes
bariatric surgery
hydrogen peroxide
liver injury
mouse model
binding protein
obese patients
nitric oxide
body mass index